Gut Health in Rosacea: Diet, Probiotics, and the Microbiome
Growing evidence suggested that the skin and gut may be more closely linked than once thought — especially in chronic inflammatory conditions like rosacea. In a comprehensive review recently published in Biomolecules , Marco Manfredini, MD, from the Department of Dermatology at the University of Modena and Reggio Emilia, Modena, Italy, and colleagues explored the evolving science around how diet, gut microbiota, and probiotics may influence rosacea pathogenesis and symptom severity.
While more clinical studies are needed, the review highlighted new pathways linking gastrointestinal dysbiosis to cutaneous inflammation. The authors proposed that specific dietary modifications and the use of probiotics could support traditional treatment approaches for certain patients.
Pathogenesis of Rosacea: A Multifactorial Inflammatory Process
Rosacea arises from a complex interplay of multiple contributing factors. 'The pathogenesis of rosacea continues to be a subject of investigation,' the authors wrote, involving 'dysregulation of the innate immune response and neuropeptide activity, microbial involvement, environmental factors, dietary triggers, and skin barrier dysfunction.'
Central to these mechanisms is the innate immune system. In rosacea, elevated levels of kallikrein-5 trigger excessive processing of antimicrobial peptides into proinflammatory fragments such as LL-37. These fragments promote oxidative stress, cytokine release, and blood vessel changes, contributing to the inflammation and vascular symptoms seen in the disease, according to the authors.
Neurovascular dysregulation is also a hallmark of the disease. The authors noted, 'activation of TRPV1 [Transient Receptor Potential Cation Channel Subfamily V Member 1] and related channels by environmental triggers like heat and UV [ultraviolet] radiation exacerbate flushing and erythema by promoting vasodilation and neurogenic inflammation.' These channels are hypersensitive in patients with rosacea, contributing to enhanced symptom severity.
While the skin microbiome — particularly Demodex folliculorum and its associated Bacillus oleronius — has long been considered a contributing factor, recent attention has turned to the gut.
'Emerging evidence suggests that while microorganisms may not be central causative factors… alterations in the skin microbiome across multiple rosacea subtypes may act as trigger factors or potentiate inflammation,' the review authors wrote. 'Gastrointestinal dysbiosis, including conditions such as Helicobacter pylori infection and small intestinal bacterial overgrowth (SIBO),' they noted, 'has been hypothesized as a potential contributor to rosacea development.'
Gut Dysbiosis and the Skin: The Available Evidence
The concept of a gut–skin axis describes the bidirectional relationship between intestinal microbiota and skin inflammation. In rosacea, this relationship is supported by associations with conditions like SIBO, H pylori infection, and inflammatory bowel diseases, as highlighted in the Manfredini review.
Asked to comment on this emerging topic, Rajani Katta, MD, clinical professor of dermatology at the McGovern Medical School, University of Texas, Houston, noted, 'We have strong evidence linking gut dysbiosis to rosacea, but it is important to note that this applies only to certain patients. In other words, only a subset of patients with rosacea seems to have gut dysbiosis, and in those patients, there appears to be a link.'
Rajani Katta, MD
Katta added that the most compelling mechanisms relate to inflammation. 'Patients with SIBO may have higher levels of inflammatory mediators, such as tumor necrosis factor alpha. In other studies, gut dysbiosis can lead to the activation of specific inflammatory pathways like the kallikrein-kinin pathway. Activation of these pathways has multiple downstream effects, which may ultimately increase neurogenic inflammation in the skin.'
The review by Manfredini and colleagues supported these theories, citing studies that show improvement in rosacea symptoms following SIBO eradication, although the benefit of H pylori treatment is less clear.
'The association between Helicobacter pylori infection and rosacea remains complex and influenced by several confounding factors,' the authors wrote. 'The antibiotic treatment required for H pylori eradication represents an important confounding factor.' The authors caution that without large-scale prospective studies examining the gut microbiome before and after intervention, firm conclusions about causality remain elusive.
Dietary Triggers: What the Evidence Supports
Dietary factors may influence rosacea by promoting vasodilation, activating sensory receptors, or altering the gut microbiome. Yet, data on specific triggers remain mixed, according to the authors.
Asked to comment on dietary triggers in rosacea, Lauren Kole, MD, associate professor of dermatology at the University of Alabama at Birmingham, said that 'the best data for dietary triggers for rosacea are for alcohol and hot beverages. Alcohol may induce peripheral vasodilation, promote inflammation, modulate the immune system, and may trigger histamine release. Hot beverages may cause direct vasodilation and trigger other pathways that lead to flushing, stinging, and sensitive skin.'
Katta also noted that alcohol and hot beverages 'are common triggers, likely because they lead to vasodilation, which causes flushing.' She also highlighted spicy foods as a culprit. 'Foods that contain capsaicin may result in vasodilation and thus flare rosacea, so avoiding spicy foods may be helpful.' Another category included foods that contain cinnamaldehyde — a compound found in cinnamon, tomatoes, and citrus —which may trigger flushing in sensitive individuals, according to Katta.
Katta recommended a practical approach for patients. 'For most patients, a 6-week trial of eliminating the most commonly reported food triggers in rosacea is a good first step… I tell patients that it can take 6 weeks of avoiding these foods to see if it will be helpful, and I recommend a food diary.'
Interestingly, certain foods may offer benefits. Dairy products have been associated with reduced rosacea severity in some populations, potentially because of their anti-inflammatory effects. High-fiber diets may support gut microbial diversity and caffeine — despite its reputation — has been inversely associated with rosacea in large observational studies, cited in the Manfredini review.
Probiotics: Potential but Preliminary
Probiotics are another area of growing interest. These live microorganisms may influence rosacea by rebalancing the gut microbiome, reducing inflammatory cytokine production, and enhancing skin barrier function, according to the authors.
'Dietary probiotics may help normalize skin dysbiosis in rosacea and may limit substance P-induced skin inflammation,' said Kole. She referenced a study that found improved skin barrier function and reduced sensitivity with oral probiotic use alongside doxycycline therapy.
Katta said that she has not used probiotics for rosacea in her practice. 'Preliminary results appear intriguing, but there are still many questions about the optimal strain of probiotics as well as dose and duration,' she told Medscape Medical News . She added that the current evidence is 'too preliminary to recommend specific strains or delivery routes, although some have shown benefit,' referencing studies on strains of Bifidobacterium , Lactobacillus , and Escherichia coli Nissle included in the Manfredini review.
Topical formulations are also being explored with promising results, and a product containing Vitreoscilla filiformis has shown reductions in facial erythema and Demodex density while improving transepidermal water loss, according to the review's authors.
However, mirroring Katta's sentiment, the authors concluded that 'despite promising results, the evidence supporting the use of probiotics in the treatment of rosacea remains relatively limited. Further clinical trials are necessary to evaluate and compare the effectiveness of various probiotic strains and different methods of delivery, such as oral ingestion and topical use.'
Looking Ahead: Clinical Considerations and Research Needs
While the current research is promising, more rigorous studies are needed. 'One of the research areas that I'd love to see more of,' Katta said, 'is measuring rates of gut dysbiosis in patients with rosacea, with prospective studies examining gut microbiome composition before and after treatment, and how that correlates to rosacea severity.'
For now, clinicians may consider an individualized approach, she said, and asking about gastrointestinal symptoms, evaluating for common dietary triggers, and discussing a food elimination trial can be helpful strategies. Although formal probiotic guidelines for rosacea are lacking, some patients may benefit from a monitored trial of supplementation — particularly if they also have gut-related complaints, she added.
'There are many gaps in our understanding of the gut–skin axis,' Katta emphasized. 'But it's an exciting area of dermatologic research.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Associated Press
2 hours ago
- Associated Press
Benchmark Data for Dealmakers - Access Deal Records of Actual Deals As Disclosed by the Deal Parties
DUBLIN--(BUSINESS WIRE)--Jun 23, 2025-- The 'Precision Medicine Collaboration and Licensing Deals 2019-2025" has been added to offering. This report contains a comprehensive listing of 1,221 precision medicine deals announced since 2019, including financial terms where available, and links to online deal records of actual precision medicine partnering deals as disclosed by the deal parties. In addition, where available, records include contract documents as submitted to the Securities Exchange Commission by companies and their partners. Precision Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to the precision medicine deals entered into by the world's leading biopharma companies. Fully revised and updated, the report provides details of precision medicine deals from 2019 to 2025. The report provides a detailed understanding and analysis of how and why companies enter precision medicine deals. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes. The report includes collaboration, development, research, and licensing deals. The initial chapters of the report offer an overview of precision medicine dealmaking. Chapter 1 serves as an introduction, while Chapter 2 outlines the trends in precision medicine dealmaking since 2019. Chapter 3 highlights leading precision medicine deals by headline value, and Chapter 4 lists the top 25 most active companies with summaries and listings of deals. Chapters 5 and 6 provide detailed reviews of deals announced since Jan 2019, organized by contractor availability and technology focus respectively. Precision Medicine Collaboration and Licensing Deals provides the reader with the following key benefits: Precision Medicine Collaboration and Licensing Deals includes: Analyzing contract agreements allows due diligence of: Key Topics Covered: Executive Summary Chapter 1 - Introduction Chapter 2 - Trends in precision medicine dealmaking 2.1. Introduction 2.2. Precision medicine deals over the years 2.3. Most active precision medicine dealmakers 2.4. Precision medicine deals by deal type 2.5. Precision medicine deals by therapy area 2.6. Precision medicine deals by industry sector 2.7. Deal terms for precision medicine deals 2.7.1 Precision medicine deals headline values 2.7.2 Precision medicine deal upfront payments 2.7.3 Precision medicine deal milestone payments 2.7.4 Precision medicine royalty rates Chapter 3 - Leading precision medicine deals 3.1. Introduction 3.2. Top precision medicine deals by value Chapter 4 - Most active precision medicine dealmakers 4.1. Introduction 4.2. Most active precision medicine dealmakers 4.3. Most active precision medicine deals company profiles Chapter 5 - Precision medicine contracts dealmaking directory 5.1. Introduction 5.2. Precision medicine contracts dealmaking directory Chapter 6 - Precision medicine dealmaking by technology type Deal directory Companies Featured For more information about this report visit About is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. View source version on CONTACT: Laura Wood, Senior Press Manager [email protected] For E.S.T Office Hours Call 1-917-300-0470 For U.S./ CAN Toll Free Call 1-800-526-8630 For GMT Office Hours Call +353-1-416-8900 KEYWORD: INDUSTRY KEYWORD: BIOTECHNOLOGY GENERAL HEALTH PHARMACEUTICAL HEALTH SOURCE: Research and Markets Copyright Business Wire 2025. PUB: 06/23/2025 01:09 PM/DISC: 06/23/2025 01:08 PM
Gizmodo
3 hours ago
- Gizmodo
Frequent Nightmares Linked to Faster Aging and Premature Death
If you often have nightmares, you may need to worry a bit more about your health. New research presented today at the European Academy of Neurology (EAN) Congress 2025 links frequent nightmares to faster biological aging and an over three times higher risk of premature death, even when taking into account other medical conditions. The researchers claim to be the first to demonstrate this association, which could have significant implications for how seriously one should consider persistent nightmares. 'Our sleeping brains cannot distinguish dreams from reality,' Abidemi Otaiku, a neuroscientist at Imperial College London and presumably an author of a forthcoming study, explained in an EAN press release. 'That's why nightmares often wake us up sweating, gasping for breath, and with our hearts pounding – because our fight-or-flight response has been triggered. This stress reaction can be even more intense than anything we experience while awake.' Simply put, researchers tracked the nightmare frequency of adults and children (whose nightmares were reported by their parents) for time periods of up to 19 years. Their results demonstrate that both children and adults who often have nightmares experience accelerated biological aging. Adults who suffered from weekly nightmares were also more than three times as likely to die before the age of 70 as those who rarely or never had nightmares, with the faster biological aging accounting for around 40% of that increased early mortality risk. 'Nightmares lead to prolonged elevations of cortisol, a stress hormone closely linked to faster cellular ageing,' Otaiku added. 'For those who frequently experience nightmares, this cumulative stress may significantly impact the ageing process. Additionally, nightmares disrupt both sleep quality and duration, impairing the body's essential overnight cellular restoration and repair. The combined effects of chronic stress and disrupted sleep likely contribute to the accelerated ageing of our cells and bodies.' Specifically, the link between chronic nightmares and faster aging was consistent in participants of all sexes, ages, mental health statuses, and ethnicities. Biological aging was measured by looking at people's telomeres, the protective end caps of chromosomes. Shorter telomeres are widely considered to be a sign of greater biological age. Furthermore, the research revealed weekly nightmares to more strongly predict early death than other widely known causes, including obesity, smoking, a bad diet, and low physical activity. Even less frequent nightmares, however, had their toll. Participants who reported having them monthly also experienced faster aging and increased premature mortality compared to those who reported rare or no nightmares. As if living through terrifying experiences at night wasn't bad enough, the associated health consequences highlighted in the new research carry important implications for how seriously we should take nightmares. And if we're being honest, the state of plastic pollution and human-driven accelerated geological processes are probably not helping in that category, either.
Gizmodo
3 hours ago
- Gizmodo
Scientists Just Found a New, Incredibly Rare Blood Type
Step aside A, B, and O—there's a new player in town. Scientists in France have just reported the discovery of a novel, rare blood type, only recorded in a single person to date. The French Blood Establishment (EFS), the country's sole civilian blood transfusion organization, announced the discovery over the weekend. The blood type, nicknamed 'Gwada negative,' was found in a French woman originally from Guadeloupe. It's the 48th distinct blood group system to be established. 'This discovery was officially recognized in early June in Milan by the International Society of Blood Transfusion,' the EFS said in a statement released on LinkedIn Friday. The 'Man With the Golden Arm': Blood Donor Who Saved Millions Dies at 88 It's taken a long while for this recognition to happen. Researchers at the EFS first noticed an unusual antibody in the woman's blood in 2011, after she provided a sample for routine examination before a surgery in her early 50s. But they simply didn't have the resources or technology needed at the time to look further into it. Finally, in 2019, they were able to perform 'high-throughput DNA sequencing' of the woman's genetics, which confirmed she possessed a unique blood-related mutation inherited from both her parents. Her blood type appears to be the result of having both copies of this mutation, since her siblings have one copy and don't have it. The blood type is formally called PIGZ, with Gwada negative being a reference to the woman's Guadeloupean origin (Guadeloupe is an French island region in the Caribbean). So far, she seems to be one of a kind. 'She is the only person in the world who is compatible with herself,' Thierry Peyrard, a medical biologist at the EFS who helped discover the blood type, told the AFP. Donated Blood Is Safe No Matter a Person's Sex, Large Trial Finds Blood types refer to the particular combinations of antigens that cover our red blood cells. The most commonly found antigens belong to the ABO blood group, but scientists have discovered over 600 separate antigens that can be sorted into dozens of blood groups. Knowing our blood type is important, since our body's immune system can generate antibodies that attack blood cells from someone with a blood type incompatible with ours. This not only complicates blood donation but pregnancy. So aside from simple curiosity, categorizing Gwada negative and other rare blood types can be medically vital. 'Discovering new blood types means offering patients with rare blood a better level of care,' the EFS said. Peyrard and his colleagues are now hoping to find others with the woman's blood type, and will first plan to look for it among blood donors in Guadeloupe.
